s6y

Clearside Biomedical, Inc.

CIK
1539029
Industry
Pharmaceutical Preparations

Financials 38

  1. 10-Q Quarterly Report for period ending Sep 30, 2025
  2. 10-Q Quarterly Report for period ending Jun 30, 2025
  3. 10-Q Quarterly Report for period ending Mar 31, 2025
  4. 10-K Annual Report for period ending Dec 31, 2024
  5. 10-Q Quarterly Report for period ending Sep 30, 2024
  6. 10-Q Quarterly Report for period ending Jun 30, 2024
  7. 10-Q Quarterly Report for period ending Mar 31, 2024
  8. 10-K Annual Report for period ending Dec 31, 2023
  9. 10-Q Quarterly Report for period ending Sep 30, 2023
  10. 10-Q Quarterly Report for period ending Jun 30, 2023

All 38 financials filings

News 118

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 118 news filings

Ownership 265

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 3/A Initial statement of beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 265 ownership filings

Prospectus 55

  1. S-8 POS Post-effective amendment to a S-8 registration statement
  2. S-8 POS Post-effective amendment to a S-8 registration statement
  3. S-8 POS Post-effective amendment to a S-8 registration statement
  4. S-8 POS Post-effective amendment to a S-8 registration statement
  5. S-8 POS Post-effective amendment to a S-8 registration statement
  6. S-8 POS Post-effective amendment to a S-8 registration statement
  7. S-8 POS Post-effective amendment to a S-8 registration statement
  8. S-8 POS Post-effective amendment to a S-8 registration statement
  9. S-8 POS Post-effective amendment to a S-8 registration statement
  10. S-8 POS Post-effective amendment to a S-8 registration statement

All 55 prospectus filings

Proxies 21

  1. DEF 14A Definitive proxy statements
  2. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  3. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  4. DEF 14A Definitive proxy statements
  5. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  6. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  7. DEF 14A Definitive proxy statements
  8. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  9. DEF 14A Definitive proxy statements
  10. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

All 21 proxies filings

Other 55

  1. 15-12G Notice of termination of registration of a class of securities under Section 12(g)
  2. EFFECT Notice of Effectiveness
  3. EFFECT Notice of Effectiveness
  4. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  5. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  6. 25 Notification filed by issuer to voluntarily withdraw a class of securities from listing and registration on a national securities exchange
  7. ARS Annual report to security holders
  8. SCHEDULE 13G
  9. SCHEDULE 13G/A
  10. SCHEDULE 13D/A

All 55 other filings